COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy (E2LDX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01986764
Recruitment Status : Withdrawn (Funding was not obtained for this study and no participants were enrolled.)
First Posted : November 18, 2013
Last Update Posted : March 24, 2017
Information provided by (Responsible Party):
C. Neill Epperson, University of Pennsylvania

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : July 1, 2013
Actual Study Completion Date : July 1, 2013